Uncover key drivers, emerging technologies, and competitive movements shaping the intravenous (iv) compounding automation market from 2026–2035 with trusted insights from The Business Research Company
What are the forecasted starting (2026) and ending (2030) market sizes for the Automated Immunoassay Analyzers Market?
The automated immunoassay analyzers market has experienced swift expansion in recent years. This market is projected to expand from $23.09 billion in 2025 to $26.39 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.3%. The historical growth can be attributed to the enlargement of centralized clinical laboratories, an increase in routine immunoassay testing volumes, the proliferation of disease screening programs, the early automation of laboratory workflows, and the adoption of immunoassay systems for monitoring infectious diseases.
The market for automated immunoassay analyzers is projected to experience substantial expansion in the coming years. This market is anticipated to reach $44.93 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.2%. This growth over the forecast period is attributable to several factors, including the increasing demand for chronic and endocrine disorder testing, the expansion of oncology and biomarker testing, the need for quicker diagnostic outcomes, the greater adoption of automated systems in research laboratories, and the broadening of pharmaceutical and biotech research and development testing applications. Key trends expected during this period involve a rising need for high-throughput diagnostic tests, greater implementation in infectious disease and endocrinology diagnostics, wider deployment of automated testing within research and academic settings, increased use in therapeutic drug monitoring and oncology diagnostics, and the standardization of lab processes to enhance testing effectiveness.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18232&type=smp
What Drivers Are Supporting Technological Adoption In The Automated Immunoassay Analyzers Market?
The expansion in the count of hospitals is anticipated to fuel the future expansion of the automated immunoassay analyzers market. Hospitals are defined as healthcare facilities offering medical, surgical, and diagnostic services for individuals needing treatment or emergency attention. These establishments operate as structured sites with healthcare professionals providing both inpatient and outpatient care across diverse specializations. The count of hospitals is escalating because of heightened healthcare demands stemming from an expanding and aging demographic. Automated immunoassay analyzers boost efficiency and precision within hospitals by quickly processing extensive quantities of diagnostic tests for numerous illnesses and conditions. As an illustration, the American Health Care Association, a US-based nonprofit entity, reported in May 2023 that the number of hospitals in the US grew to 6,129 in 2023 from 6,093 in 2022, marking a rise of 0.59%. Consequently, the growing count of hospitals is stimulating the development of the automated immunoassay analyzers market.
What Segment Types Are Examined In The Automated Immunoassay Analyzers Market?
The automated immunoassay analyzers market covered in this report is segmented –
1) By Product: Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System (ELISA), Multiplexed Assay System, Radioimmunoassay
2) By Application: Infectious Diseases, Endocrinology, Drug Monitoring, Cardiology, Oncology, Allergy Testing, Other Applications
3) By End-User: Hospitals, Diagnostic Laboratories, Research And Academic Laboratories, Pharmaceutical And Biotechnology Companies, Other End-Users
Subsegments:
1) By Immunofluorescence: Fluorescent Labeling Kits, Fluorescent Detectors And Readers, Immunofluorescence Reagents
2) By Chemiluminescence: Chemiluminescent Labels And Reagents, Chemiluminescence Detectors And Readers, Chemiluminescent Assay Kits
3) By Enzyme Linked Fluorescent System (ELISA): ELISA Kits (Capture And Detection Kits), ELISA Microplates And Plates Coating Systems, Enzyme Substrates And Detection Reagents
4) By Multiplexed Assay System: Multiplexed Assay Kits, Multi-Analyte Detection Systems, Multiplexing Software And Data Analysis Tools
5) By Radioimmunoassay (RIA): Radioactive Isotope Kits, Gamma Counters, Radiolabeled Reagents
What Industry Trends Are Transforming The Automated Immunoassay Analyzers Market?
Leading companies in the automated immunoassay analyzers market are concentrating on developing innovative products, such as compact immunoassay analyzers, to gain a competitive edge. These compact immunoassay analyzers are smaller, portable devices engineered for conducting immunoassay tests that detect specific biomarkers in biological samples. They provide convenience and enhanced efficiency in various healthcare settings, especially where space and mobility are restricted. For instance, in July 2023, Siemens Healthineers, a Germany-based healthcare company, introduced the Atellica CI Analyzer, a compact laboratory testing system designed to boost efficiency in both immunoassay and clinical chemistry testing. By integrating these two testing methods into a single platform, the Atellica CI Analyzer addresses the increasing demand for versatile systems capable of performing diverse tests efficiently. The features of this product are well-aligned with current market trends, effectively tackling the challenges laboratories encounter in delivering timely and accurate diagnostic results. Capabilities like random access sampling, micro-volume aspiration, and automated maintenance and quality control scheduling assist laboratories in achieving more consistent and predictable sample processing times.
Who Are The Major Companies Operating In The Automated Immunoassay Analyzers Market?
Major companies operating in the automated immunoassay analyzers market are Roche Diagnostics AG, Abbott Laboratories, Danaher Corporation, Siemens Healthineers, Becton Dickinson and Company, Tosoh Corporation, bioMérieux SA, QuidelOrtho Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc, Qiagen NV, Werfen Group SA, DiaSorin SpA, Bio-Techne Corporation, Meril Life Sciences Private Limited, Randox Laboratories Ltd, Getein Biotech Inc, Aesku Diagnostics GmbH & Co KG, Carolina Liquid Chemistries Corporation, Chengdu Seamaty Technology Co Ltd, Hipro Biotechnology Co Ltd
Access The Complete Report For Deeper Market Insights:
Which Region Is Anticipated To See The Fastest Growth In The Automated Immunoassay Analyzers Market?
North America was the largest region in the automated immunoassay analyzer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated immunoassay analyzers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Automated Immunoassay Analyzers Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=18232&type=smp
Browse Through More Reports Similar to the Global Automated Immunoassay Analyzers Market 2026, By The Business Research Company
Immunohematology Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report
Immunodiagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunodiagnostics-global-market-report
Immunoassay Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/immunoassay-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company